Outcomes of total joint arthroplasty in HIV patients

Jonathan Falakassa, Alejandro Diaz, Michaela Schneiderbauer

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

BACKGROUND: Advancement in human immunodeficiency virus (HIV) therapies has increased life expectancy. The need for joint replacement is expected to increase as this population develops degenerative changes from aging and avascular necrosis (AVN). Studies have shown a higher risk of peri-prosthetic joint infections (PJI) in HIV patients. However, these studies include a high percentage of hemophiliacs, which may be a confounding variable. With the advent of highly active anti-retroviral therapy (HAART) and evolving HIV demographics, we hypothesize the rate of PJIs in HIV patients are comparable to the general population.

METHODS: We performed a retrospective cohort study using prospectively collected data from our arthroplasty database. We identified 24 HIV patients that underwent 31 primary hip and one primary knee arthroplasty between July 1, 2000 and September 30, 2012. Mean age was 50 years (range 31-74). Mean follow-up was 14 months (range 1.5-60).

RESULTS: There were no PJIs in our HIV population. All HIV patients were non-hemophiliacs on HAART. Thirty-one total hip arthroplasties (THA) and one total knee arthroplasty were performed. Twenty-one HIV patients underwent THA for AVN. Eight patients had bilateral AVN. One patient needed revision for aseptic loosening. The mean CD4 count was 647 (194-1193). Mean viral load was undetectable in 19 patients and unavailable in five.

CONCLUSIONS: Our HIV population had a lower rate of PJI compared to infection rates in prior literature. Despite our limited patient population, our data suggests that well controlled HIV patients on HAART therapy with undetectable viral loads and CD4 >200 are at similar risk of PJI as the average population.

Original languageEnglish (US)
Pages (from-to)102-106
Number of pages5
JournalThe Iowa orthopaedic journal
Volume34
StatePublished - 2014

Fingerprint

Arthroplasty
Joints
HIV
Population
Hip
Knee Replacement Arthroplasties
Necrosis
Infection
Viral Load
Replacement Arthroplasties
Therapeutics
Confounding Factors (Epidemiology)
CD4 Lymphocyte Count
Life Expectancy
Cohort Studies
Retrospective Studies
Demography
Databases

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Outcomes of total joint arthroplasty in HIV patients. / Falakassa, Jonathan; Diaz, Alejandro; Schneiderbauer, Michaela.

In: The Iowa orthopaedic journal, Vol. 34, 2014, p. 102-106.

Research output: Contribution to journalArticle

Falakassa, Jonathan ; Diaz, Alejandro ; Schneiderbauer, Michaela. / Outcomes of total joint arthroplasty in HIV patients. In: The Iowa orthopaedic journal. 2014 ; Vol. 34. pp. 102-106.
@article{1024de079f414424ac0048e659380989,
title = "Outcomes of total joint arthroplasty in HIV patients",
abstract = "BACKGROUND: Advancement in human immunodeficiency virus (HIV) therapies has increased life expectancy. The need for joint replacement is expected to increase as this population develops degenerative changes from aging and avascular necrosis (AVN). Studies have shown a higher risk of peri-prosthetic joint infections (PJI) in HIV patients. However, these studies include a high percentage of hemophiliacs, which may be a confounding variable. With the advent of highly active anti-retroviral therapy (HAART) and evolving HIV demographics, we hypothesize the rate of PJIs in HIV patients are comparable to the general population.METHODS: We performed a retrospective cohort study using prospectively collected data from our arthroplasty database. We identified 24 HIV patients that underwent 31 primary hip and one primary knee arthroplasty between July 1, 2000 and September 30, 2012. Mean age was 50 years (range 31-74). Mean follow-up was 14 months (range 1.5-60).RESULTS: There were no PJIs in our HIV population. All HIV patients were non-hemophiliacs on HAART. Thirty-one total hip arthroplasties (THA) and one total knee arthroplasty were performed. Twenty-one HIV patients underwent THA for AVN. Eight patients had bilateral AVN. One patient needed revision for aseptic loosening. The mean CD4 count was 647 (194-1193). Mean viral load was undetectable in 19 patients and unavailable in five.CONCLUSIONS: Our HIV population had a lower rate of PJI compared to infection rates in prior literature. Despite our limited patient population, our data suggests that well controlled HIV patients on HAART therapy with undetectable viral loads and CD4 >200 are at similar risk of PJI as the average population.",
author = "Jonathan Falakassa and Alejandro Diaz and Michaela Schneiderbauer",
year = "2014",
language = "English (US)",
volume = "34",
pages = "102--106",
journal = "The Iowa orthopaedic journal",
issn = "1541-5457",
publisher = "University of Iowa",

}

TY - JOUR

T1 - Outcomes of total joint arthroplasty in HIV patients

AU - Falakassa, Jonathan

AU - Diaz, Alejandro

AU - Schneiderbauer, Michaela

PY - 2014

Y1 - 2014

N2 - BACKGROUND: Advancement in human immunodeficiency virus (HIV) therapies has increased life expectancy. The need for joint replacement is expected to increase as this population develops degenerative changes from aging and avascular necrosis (AVN). Studies have shown a higher risk of peri-prosthetic joint infections (PJI) in HIV patients. However, these studies include a high percentage of hemophiliacs, which may be a confounding variable. With the advent of highly active anti-retroviral therapy (HAART) and evolving HIV demographics, we hypothesize the rate of PJIs in HIV patients are comparable to the general population.METHODS: We performed a retrospective cohort study using prospectively collected data from our arthroplasty database. We identified 24 HIV patients that underwent 31 primary hip and one primary knee arthroplasty between July 1, 2000 and September 30, 2012. Mean age was 50 years (range 31-74). Mean follow-up was 14 months (range 1.5-60).RESULTS: There were no PJIs in our HIV population. All HIV patients were non-hemophiliacs on HAART. Thirty-one total hip arthroplasties (THA) and one total knee arthroplasty were performed. Twenty-one HIV patients underwent THA for AVN. Eight patients had bilateral AVN. One patient needed revision for aseptic loosening. The mean CD4 count was 647 (194-1193). Mean viral load was undetectable in 19 patients and unavailable in five.CONCLUSIONS: Our HIV population had a lower rate of PJI compared to infection rates in prior literature. Despite our limited patient population, our data suggests that well controlled HIV patients on HAART therapy with undetectable viral loads and CD4 >200 are at similar risk of PJI as the average population.

AB - BACKGROUND: Advancement in human immunodeficiency virus (HIV) therapies has increased life expectancy. The need for joint replacement is expected to increase as this population develops degenerative changes from aging and avascular necrosis (AVN). Studies have shown a higher risk of peri-prosthetic joint infections (PJI) in HIV patients. However, these studies include a high percentage of hemophiliacs, which may be a confounding variable. With the advent of highly active anti-retroviral therapy (HAART) and evolving HIV demographics, we hypothesize the rate of PJIs in HIV patients are comparable to the general population.METHODS: We performed a retrospective cohort study using prospectively collected data from our arthroplasty database. We identified 24 HIV patients that underwent 31 primary hip and one primary knee arthroplasty between July 1, 2000 and September 30, 2012. Mean age was 50 years (range 31-74). Mean follow-up was 14 months (range 1.5-60).RESULTS: There were no PJIs in our HIV population. All HIV patients were non-hemophiliacs on HAART. Thirty-one total hip arthroplasties (THA) and one total knee arthroplasty were performed. Twenty-one HIV patients underwent THA for AVN. Eight patients had bilateral AVN. One patient needed revision for aseptic loosening. The mean CD4 count was 647 (194-1193). Mean viral load was undetectable in 19 patients and unavailable in five.CONCLUSIONS: Our HIV population had a lower rate of PJI compared to infection rates in prior literature. Despite our limited patient population, our data suggests that well controlled HIV patients on HAART therapy with undetectable viral loads and CD4 >200 are at similar risk of PJI as the average population.

UR - http://www.scopus.com/inward/record.url?scp=84932090935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84932090935&partnerID=8YFLogxK

M3 - Article

VL - 34

SP - 102

EP - 106

JO - The Iowa orthopaedic journal

JF - The Iowa orthopaedic journal

SN - 1541-5457

ER -